K DeSombre
-
- HER2/EGFR in Cancer Research 5
- Cancer Cells and Metastasis 4
-
- Monoclonal and Polyclonal Antibodies Research 6
- Reproductive Medicine top 10%
-
- Breast Lesions and Carcinomas 1
-
- Toxin Mechanisms and Immunotoxins 4
-
- Glycosylation and Glycoproteins Research 2
-
- Virus-based gene therapy research 1
- Genetic Associations and Epidemiology 1
- Co-authors
- Robert C. BastAndrew BerchuckC. BoyerRegina S. WhitakerS J McKenzieDonna HollisCinda M. BoyerW. P. Peters
- Journals
- Journal of Clinical Oncology (1 paper)Cancer (1 paper)The American Journal of Human Genetics (1 paper)
- Partner nations
- United States
In The Last Decade
K DeSombre
12 papers receiving 418 citations
Peers
Comparison fields: 5 of 58
- Oncology 203
- Radiology, Nuclear Medicine and Imaging 131
- Reproductive Medicine 46
- Pathology and Forensic Medicine 87
- Immunology 96
Countries citing papers authored by K DeSombre
This map shows the geographic impact of K DeSombre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K DeSombre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K DeSombre more than expected).
Fields of papers citing papers by K DeSombre
This network shows the impact of papers produced by K DeSombre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K DeSombre. The network helps show where K DeSombre may publish in the future.
Co-authorship network
The 25 scholars most cited alongside K DeSombre, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 104 | |
| 2 | Synergistic interaction between anti-p185HER-2 ricin A chain immunotoxins and radionuclide conjugates for inhibiting growth of ovarian and breast cancer cells that overexpress HER-2. | 2000 | 11 |
| 3 | 1999 | 21 | |
| 4 | Cell surface density of p185(c-erbB-2) determines susceptibility to anti-p185(c-erbB-2)-ricin A chain (RTA) immunotoxin therapy alone and in combination with anti-p170(EGFR)-RTA in ovarian cancer cells. | 1998 | 24 |
| 5 | 1998 | 22 | |
| 6 | The significance of tumor contamination in the bone marrow from high-risk primary breast cancer patients treated with high-dose chemotherapy and hematopoietic support. | 1997 | 34 |
| 7 | 1996 | 25 | |
| 8 | Detection of tumor cells in the bone marrow of stage IV breast cancer patients receiving high-dose chemotherapy: the role of induction chemotherapy. | 1995 | 12 |
| 9 | 1993 | 74 | |
| 10 | 1993 | 53 | |
| 11 | 1993 | 38 | |
| 12 | 1992 | 14 |
About K DeSombre
K DeSombre is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Immunology, having authored 12 papers that have together received 432 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (6 papers), HER2/EGFR in Cancer Research (5 papers), Toxin Mechanisms and Immunotoxins (4 papers), Cancer Cells and Metastasis (4 papers), Glycosylation and Glycoproteins Research (2 papers), Virus-based gene therapy research (1 paper), Genetic Associations and Epidemiology (1 paper) and Breast Lesions and Carcinomas (1 paper). The work is most often cited by research in Oncology (203 citations), Radiology, Nuclear Medicine and Imaging (131 citations) and Reproductive Medicine (46 citations). K DeSombre has collaborated with scholars based in United States. Frequent co-authors include Robert C. Bast, Andrew Berchuck, C. Boyer, Regina S. Whitaker, S J McKenzie, Donna Hollis, Cinda M. Boyer, W. P. Peters, James J. Vredenburgh and Ann M. Saunders. Their work appears in journals such as Journal of Clinical Oncology, Cancer and The American Journal of Human Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.